{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:22:43Z","timestamp":1793384563828,"version":"4.5.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>MicroRNAs (miRNAs) are a new class of short noncoding regulatory RNAs (18\u201325 nucleotides) that are involved in diverse developmental and pathologic processes. Altered miRNA expression has been associated with several types of human cancer. However, most studies did not establish whether miRNA expression changes occurred within cells undergoing malignant transformation. To obtain insight into miRNA deregulation in breast cancer, we implemented an in situ hybridization (ISH) method to reveal the spatial distribution of miRNA expression in archived formalin-fixed, paraffin-embedded specimens representing normal and tumor tissue from &amp;gt;100 patient cases. Here, we report that expression of miR-145 and miR-205 was restricted to the myoepithelial\/basal cell compartment of normal mammary ducts and lobules, whereas their accumulation was reduced or completely eliminated in matching tumor specimens. Conversely, expression of other miRNAs was detected at varying levels predominantly within luminal epithelial cells in normal tissue; expression of miR-21 was frequently increased, whereas that of let-7a was decreased in malignant cells. We also analyzed the association of miRNA expression with that of epithelial markers; prognostic indicators such as estrogen receptor, progesterone receptor, and HER2; as well as clinical outcome data. This ISH approach provides a more direct and informative assessment of how altered miRNA expression contributes to breast carcinogenesis compared with miRNA expression profiling in gross tissue biopsies. Most significantly, early manifestation of altered miR-145 expression in atypical hyperplasia and carcinoma in situ lesions suggests that this miRNA may have a potential clinical application as a novel biomarker for early detection. [Cancer Res 2007;67(24):11612\u201320]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-5019","type":"journal-article","created":{"date-parts":[[2007,12,18]],"date-time":"2007-12-18T13:52:12Z","timestamp":1197985932000},"page":"11612-11620","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":465,"title":["Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer"],"prefix":"10.1158","volume":"67","author":[{"given":"Lorenzo F.","family":"Sempere","sequence":"first","affiliation":[{"name":"1Biochemistry, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Christensen","sequence":"additional","affiliation":[{"name":"4Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asli","family":"Silahtaroglu","sequence":"additional","affiliation":[{"name":"4Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Bak","sequence":"additional","affiliation":[{"name":"4Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine V.","family":"Heath","sequence":"additional","affiliation":[{"name":"1Biochemistry, Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Schwartz","sequence":"additional","affiliation":[{"name":"5Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Wells","sequence":"additional","affiliation":[{"name":"2Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakari","family":"Kauppinen","sequence":"additional","affiliation":[{"name":"4Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark;"},{"name":"6Santaris Pharma, H\u00f8rsholm, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Cole","sequence":"additional","affiliation":[{"name":"1Biochemistry, Departments of"},{"name":"3Genetics, Dartmouth Medical School, Hanover, New Hampshire;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,12,18]]},"reference":[{"key":"2022061623230333900_B1","doi-asserted-by":"crossref","unstructured":"Ambros V. The functions of animal microRNAs. Nature\u20082004; 431: 350\u20135.","DOI":"10.1038\/nature02871"},{"key":"2022061623230333900_B2","doi-asserted-by":"crossref","unstructured":"Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet\u20082004; 5: 396\u2013400.","DOI":"10.1038\/nrg1328"},{"key":"2022061623230333900_B3","doi-asserted-by":"crossref","unstructured":"Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell\u20082006; 11: 441\u201350.","DOI":"10.1016\/j.devcel.2006.09.009"},{"key":"2022061623230333900_B4","doi-asserted-by":"crossref","unstructured":"Zeng Y. Principles of micro-RNA production and maturation. Oncogene\u20082006; 25: 6156\u201362.","DOI":"10.1038\/sj.onc.1209908"},{"key":"2022061623230333900_B5","doi-asserted-by":"crossref","unstructured":"Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev\u20082006; 20: 515\u201324.","DOI":"10.1101\/gad.1399806"},{"key":"2022061623230333900_B6","doi-asserted-by":"crossref","unstructured":"Bentwich I, Avniel A, Karov Y, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet\u20082005; 37: 766\u201370.","DOI":"10.1038\/ng1590"},{"key":"2022061623230333900_B7","doi-asserted-by":"crossref","unstructured":"Berezikov E, van TG, Verheul M, et al. Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res\u20082006; 16: 1289\u201398.","DOI":"10.1101\/gr.5159906"},{"key":"2022061623230333900_B8","doi-asserted-by":"crossref","unstructured":"Didiano D, Hobert O. Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat Struct Mol Biol\u20082006; 13: 849\u201351.","DOI":"10.1038\/nsmb1138"},{"key":"2022061623230333900_B9","doi-asserted-by":"crossref","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell\u20082005; 120: 15\u201320.","DOI":"10.1016\/j.cell.2004.12.035"},{"key":"2022061623230333900_B10","doi-asserted-by":"crossref","unstructured":"Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol\u20082007; 302: 1\u201312.","DOI":"10.1016\/j.ydbio.2006.08.028"},{"key":"2022061623230333900_B11","doi-asserted-by":"crossref","unstructured":"Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer\u20082006; 6: 857\u201366.","DOI":"10.1038\/nrc1997"},{"key":"2022061623230333900_B12","doi-asserted-by":"crossref","unstructured":"Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A\u20082002; 99: 15524\u20139.","DOI":"10.1073\/pnas.242606799"},{"key":"2022061623230333900_B13","doi-asserted-by":"crossref","unstructured":"Calin GA, Ferracin M, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med\u20082005; 353: 1793\u2013801.","DOI":"10.1056\/NEJMoa050995"},{"key":"2022061623230333900_B14","unstructured":"Michael MZ, O' Connor SM, Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res\u20082003; 1: 882\u201391."},{"key":"2022061623230333900_B15","doi-asserted-by":"crossref","unstructured":"Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell\u20082006; 9: 189\u201398.","DOI":"10.1016\/j.ccr.2006.01.025"},{"key":"2022061623230333900_B16","doi-asserted-by":"crossref","unstructured":"Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A\u20082006; 103: 2257\u201361.","DOI":"10.1073\/pnas.0510565103"},{"key":"2022061623230333900_B17","doi-asserted-by":"crossref","unstructured":"Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature\u20082005; 435: 834\u20138.","DOI":"10.1038\/nature03702"},{"key":"2022061623230333900_B18","doi-asserted-by":"crossref","unstructured":"He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature\u20082005; 435: 828\u201333.","DOI":"10.1038\/nature03552"},{"key":"2022061623230333900_B19","doi-asserted-by":"crossref","unstructured":"Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A\u20082005; 102: 13944\u20139.","DOI":"10.1073\/pnas.0506654102"},{"key":"2022061623230333900_B20","doi-asserted-by":"crossref","unstructured":"Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell\u20082005; 120: 635\u201347.","DOI":"10.1016\/j.cell.2005.01.014"},{"key":"2022061623230333900_B21","doi-asserted-by":"crossref","unstructured":"Sorlie T. Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer\u20082004; 40: 2667\u201375.","DOI":"10.1016\/j.ejca.2004.08.021"},{"key":"2022061623230333900_B22","doi-asserted-by":"crossref","unstructured":"Sims AH, Ong KR, Clarke RB, Howell A. High-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic? Breast Cancer Res\u20082006; 8: 214.","DOI":"10.1186\/bcr1605"},{"key":"2022061623230333900_B23","doi-asserted-by":"crossref","unstructured":"Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA\u20082006; 295: 2492\u2013502.","DOI":"10.1001\/jama.295.21.2492"},{"key":"2022061623230333900_B24","doi-asserted-by":"crossref","unstructured":"Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res\u20082007; 13: 2329\u201334.","DOI":"10.1158\/1078-0432.CCR-06-1109"},{"key":"2022061623230333900_B25","doi-asserted-by":"crossref","unstructured":"Bertheau P, Turpin E, Rickman DS, et al. Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen. PLoS Med\u20082007; 4: e90.","DOI":"10.1371\/journal.pmed.0040090"},{"key":"2022061623230333900_B26","doi-asserted-by":"crossref","unstructured":"Kauppinen S, Vester B, Wengel J. Locked nucleic acid: high-affinity targeting of complementary RNA for RNomics. Handb Exp Pharmacol\u20082006; 173: 405\u201322.","DOI":"10.1007\/3-540-27262-3_21"},{"key":"2022061623230333900_B27","doi-asserted-by":"crossref","unstructured":"Koshkin AA, Wengel J. Synthesis of novel 2\u2032,3\u2032-linked bicyclic thymine ribonucleosides. J Org Chem\u20081998; 63: 2778\u201381.","DOI":"10.1021\/jo972239c"},{"key":"2022061623230333900_B28","doi-asserted-by":"crossref","unstructured":"Castoldi M, Schmidt S, Benes V, et al. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA\u20082006; 12: 913\u201320.","DOI":"10.1261\/rna.2332406"},{"key":"2022061623230333900_B29","doi-asserted-by":"crossref","unstructured":"Cole K, Truong V, Barone D, McGall G. Direct labeling of RNA with multiple biotins allows sensitive expression profiling of acute leukemia class predictor genes. Nucleic Acids Res\u20082004; 32: e86.","DOI":"10.1093\/nar\/gnh085"},{"key":"2022061623230333900_B30","doi-asserted-by":"crossref","unstructured":"Wienholds E, Kloosterman WP, Miska E, et al. MicroRNA expression in zebrafish embryonic development. Science\u20082005; 309: 310\u20131.","DOI":"10.1126\/science.1114519"},{"key":"2022061623230333900_B31","doi-asserted-by":"crossref","unstructured":"Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques\u20082003; 34: 374\u20138.","DOI":"10.2144\/03342mt01"},{"key":"2022061623230333900_B32","doi-asserted-by":"crossref","unstructured":"Huber W, von HA, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics\u20082002; 18 Suppl 1: S96\u2013104.","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96"},{"key":"2022061623230333900_B33","doi-asserted-by":"crossref","unstructured":"Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol\u20082004; 5: R13.","DOI":"10.1186\/gb-2004-5-3-r13"},{"key":"2022061623230333900_B34","doi-asserted-by":"crossref","unstructured":"Griffiths-Jones S, Grocock RJ, van DS, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res\u20082006; 34: D140\u20134.","DOI":"10.1093\/nar\/gkj112"},{"key":"2022061623230333900_B35","doi-asserted-by":"crossref","unstructured":"Neve RM, Chin K, Fridlyand J, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell\u20082006; 10: 515\u201327.","DOI":"10.1016\/j.ccr.2006.10.008"},{"key":"2022061623230333900_B36","doi-asserted-by":"crossref","unstructured":"Charafe-Jauffret E, Ginestier C, Monville F, et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene\u20082006; 25: 2273\u201384.","DOI":"10.1038\/sj.onc.1209254"},{"key":"2022061623230333900_B37","doi-asserted-by":"crossref","unstructured":"Kloosterman WP, Wienholds E, de BE, Kauppinen S, Plasterk RH. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods\u20082006; 3: 27\u20139.","DOI":"10.1038\/nmeth843"},{"key":"2022061623230333900_B38","doi-asserted-by":"crossref","unstructured":"Nelson PT, Baldwin DA, Kloosterman WP, Kauppinen S, Plasterk RH, Mourelatos Z. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA\u20082006; 12: 187\u201391.","DOI":"10.1261\/rna.2258506"},{"key":"2022061623230333900_B39","doi-asserted-by":"crossref","unstructured":"van Gijlswijk RP, Wiegant J, Vervenne R, Lasan R, Tanke HJ, Raap AK. Horseradish peroxidase-labeled oligonucleotides and fluorescent tyramides for rapid detection of chromosome-specific repeat sequences. Cytogenet Cell Genet\u20081996; 75: 258\u201362.","DOI":"10.1159\/000134496"},{"key":"2022061623230333900_B40","doi-asserted-by":"crossref","unstructured":"Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res\u20082005; 65: 7065\u201370.","DOI":"10.1158\/0008-5472.CAN-05-1783"},{"key":"2022061623230333900_B41","doi-asserted-by":"crossref","unstructured":"Hwang HW, Wentzel EA, Mendell JT. A hexanucleotide element directs microRNA nuclear import. Science\u20082007; 315: 97\u2013100.","DOI":"10.1126\/science.1136235"},{"key":"2022061623230333900_B42","doi-asserted-by":"crossref","unstructured":"Clarke C, Sandle J, Lakhani SR. Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation. J Mammary Gland Biol Neoplasia\u20082005; 10: 273\u201380.","DOI":"10.1007\/s10911-005-9587-3"},{"key":"2022061623230333900_B43","doi-asserted-by":"crossref","unstructured":"Li H, Cherukuri P, Li N, et al. Nestin is expressed in the basal\/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res\u20082007; 67: 501\u201310.","DOI":"10.1158\/0008-5472.CAN-05-4571"},{"key":"2022061623230333900_B44","doi-asserted-by":"crossref","unstructured":"Laakso M, Loman N, Borg A, Isola J. Cytokeratin 5\/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors. Mod Pathol\u20082005; 18: 1321\u20138.","DOI":"10.1038\/modpathol.3800456"},{"key":"2022061623230333900_B45","doi-asserted-by":"crossref","unstructured":"Zhan M, Miller CP, Papayannopoulou T, Stamatoyannopoulos G, Song CZ. MicroRNA expression dynamics during murine and human erythroid differentiation. Exp Hematol\u20082007; 35: 1015\u201325.","DOI":"10.1016\/j.exphem.2007.03.014"},{"key":"2022061623230333900_B46","doi-asserted-by":"crossref","unstructured":"Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A\u20082003; 100: 10393\u20138.","DOI":"10.1073\/pnas.1732912100"},{"key":"2022061623230333900_B47","doi-asserted-by":"crossref","unstructured":"Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer\u20082005; 5: 845\u201356.","DOI":"10.1038\/nrc1739"},{"key":"2022061623230333900_B48","doi-asserted-by":"crossref","unstructured":"Rae JM, Ramus SJ, Waltham M, et al. Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin Exp Metastasis\u20082004; 21: 543\u201352.","DOI":"10.1007\/s10585-004-3759-1"},{"key":"2022061623230333900_B49","doi-asserted-by":"crossref","unstructured":"Liscovitch M, Ravid D. A case study in misidentification of cancer cell lines: MCF-7\/AdrR cells (re-designated NCI\/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Lett\u20082007; 245: 350\u20132.","DOI":"10.1016\/j.canlet.2006.01.013"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/24\/11612\/2578334\/11612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/24\/11612\/2578334\/11612.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:15:52Z","timestamp":1655421352000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/24\/11612\/534007\/Altered-MicroRNA-Expression-Confined-to-Specific"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,15]]},"references-count":49,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2007,12,18]]},"published-print":{"date-parts":[[2007,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-5019","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496515","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496515.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22370742","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370742.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,15]]}}}